A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Fate Therapeutics
Alexion Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Pfizer
Novartis
Pharmacyclics LLC.
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
University of California, San Diego
Hoffmann-La Roche
University of Pittsburgh
Novartis
Dana-Farber Cancer Institute
Sanofi